Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters.

Abstract:

:An Ets-related E1A-F has been characterized as an enhancer-binding protein for the adenovirus E1A gene. Here we show, in transient expression assays, that E1A-F can activate three different subclasses of the matrix metalloproteinase gene promoters. Expressions of the chloramphenicol acetyltransferase (CAT) reporter gene under the control of stromelysin, type I collagenase and 92 kD type IV collagenase promoters were increased approximately 10- to 20-fold by co-transfection with the E1A-F expression vector. Activation levels were as much high as those obtained by exogenous expression of AP-1 transcription factor. These results suggest that E1A-F positively regulates transcriptions from matrix metalloproteinase genes that are associated with invasion and metastasis of tumor cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Higashino F,Yoshida K,Noumi T,Seiki M,Fujinaga K

subject

Has Abstract

pub_date

1995-04-06 00:00:00

pages

1461-3

issue

7

eissn

0950-9232

issn

1476-5594

journal_volume

10

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1.

    abstract::We tested the cytotoxic action of 8-hydroxyguanine (8ohG) by observing the viability of several leukemic cell lines (KG-1, U937, Jurkat and K 562) in the presence of 8-hydroxydeoxyguanosine (8ohdG), a nucleoside of 8ohG. It was found that 8ohdG showed cytotoxic action only to KG-1 and that only KG-1 showed a homozygou...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203787

    authors: Hyun JW,Choi JY,Zeng HH,Lee YS,Kim HS,Yoon SH,Chung MH

    更新日期:2000-09-14 00:00:00

  • Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation.

    abstract::The growth and progression of prostate cancer are dependent on androgens and androgen receptor (AR), which act by modulating gene expression. Utilizing a gene microarray approach, we have identified the alpha1-subunit gene of soluble guanylyl cyclase (sGC) as a novel androgen-regulated gene. A heterodimeric cytoplasmi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209956

    authors: Cai C,Chen SY,Zheng Z,Omwancha J,Lin MF,Balk SP,Shemshedini L

    更新日期:2007-03-08 00:00:00

  • The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.

    abstract::Density-enhanced protein-tyrosine phosphatase-1 (DEP-1 also CD148) is a transmembrane molecule with a single intracellular PTP domain. It has recently been proposed to function as a tumor suppressor. We have previously shown that DEP-1 dephosphorylates the activated platelet-derived growth factor (PDGF) beta-receptor ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206652

    authors: Jandt E,Denner K,Kovalenko M,Ostman A,Böhmer FD

    更新日期:2003-07-03 00:00:00

  • Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.

    abstract::SCL, GATA-1, GATA-2 and GATA-3 encode lineage restricted haemopoietic transcription factors. We have previously shown that SCL, GATA-1 and GATA-2 are expressed in multipotent progenitors prior to lineage commitment, but are down-regulated during granulocyte/monocyte differentiation. The phenomenon of gene extinction i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Murrell AM,Green AR

    更新日期:1995-02-16 00:00:00

  • Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and incurable disease. Poor prognosis is due to multiple reasons, including acquisition of resistance to gemcitabine, the first-line chemotherapeutic approach. Thus, there is a strong need for novel therapies, targeting more directly the molecular aberrations of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.270

    authors: Calabretta S,Bielli P,Passacantilli I,Pilozzi E,Fendrich V,Capurso G,Fave GD,Sette C

    更新日期:2016-04-21 00:00:00

  • Glypican-3 expression is silenced in human breast cancer.

    abstract::Glypican-3 (GPC3) is a membrane-bound heparan sulfate proteoglycan that is mutated in the Simpson-Golabi-Behmel syndrome. This is an X-linked condition characterized by overgrowth, and various visceral and skeletal dysmorphisms. The phenotype of the Simpson-Golabi-Behmel syndrome patients and GPC3-deficient mice, as w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204925

    authors: Xiang YY,Ladeda V,Filmus J

    更新日期:2001-11-01 00:00:00

  • Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins.

    abstract::Transcriptional coactivators SRC-1 and p300 specifically interact with liganded-nuclear receptors and also modulate other transcription factors, including serum response factor (SRF). Here, we report that retinoids repress transactivation by SRF and specific interactions exist between the DNA binding domains of SRF an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204695

    authors: Kim SW,Kim HJ,Jung DJ,Lee SK,Kim YS,Kim JH,Kim TS,Lee JW

    更新日期:2001-10-04 00:00:00

  • The role of Gads in hematopoietic cell signalling.

    abstract::Gads is a member of the family of SH2 and SH3 domain containing adaptor proteins that is expressed specifically in hematopoietic cells and functions in the coordination of tyrosine kinase mediated signal transduction. Gads plays a critical role in signalling from the T cell receptor by promoting the formation of a com...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204771

    authors: Liu SK,Berry DM,McGlade CJ

    更新日期:2001-10-01 00:00:00

  • Control of myeloid differentiation and survival by Stats.

    abstract::Hematopoiesis involves a complex array of growth factors that regulate the survival and proliferation of immature progenitors, influence differentiation commitment, and modulate end-stage cell functions. This mini-review is focused on the role of Stat activation in the development of myeloid cells in response to hemat...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203477

    authors: Smithgall TE,Briggs SD,Schreiner S,Lerner EC,Cheng H,Wilson MB

    更新日期:2000-05-15 00:00:00

  • The autophagic paradox in cancer therapy.

    abstract::Autophagy, hallmarked by the formation of double-membrane bound organelles known as autophagosomes, is a lysosome-dependent pathway for protein degradation. The role of autophagy in carcinogenesis is context dependent. As a tumor-suppressing mechanism in early-stage carcinogenesis, autophagy inhibits inflammation and ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2011.295

    authors: Wu WK,Coffelt SB,Cho CH,Wang XJ,Lee CW,Chan FK,Yu J,Sung JJ

    更新日期:2012-02-23 00:00:00

  • The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest.

    abstract::We have previously shown that exogenous wild type p53 induces apoptosis in the Burkitt lymphoma line BL41 that carries endogenous mutant p53, using a temperature sensitive p53 construct expressed as mutant p53 at 37 degrees C and wild type p53 at 32 degrees C (Ramqvist et al., Oncogene, 8, 1495-1500, 1993). We also fo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Okan I,Wang Y,Chen F,Hu LF,Imreh S,Klein G,Wiman KG

    更新日期:1995-09-21 00:00:00

  • Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies.

    abstract::Targeted therapeutics are potential therapeutic agents because of their selectivity and efficacy against tumors resistant to conventional therapy. The goal of this study was to determine the comparative activity of monovalent, engineered anti-Her2/neu immunotoxins fused to recombinant gelonin (rGel) to the activity of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.612

    authors: Cao Y,Marks JW,Liu Z,Cheung LH,Hittelman WN,Rosenblum MG

    更新日期:2014-01-23 00:00:00

  • Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14.

    abstract::We have previously reported on the identification of a cDNA (placenta growth factor, PlGF) coding for a novel angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). Biochemical and functional characterization of PlGF derived from t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maglione D,Guerriero V,Viglietto G,Ferraro MG,Aprelikova O,Alitalo K,Del Vecchio S,Lei KJ,Chou JY,Persico MG

    更新日期:1993-04-01 00:00:00

  • Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.

    abstract::Upstream stimulating factor (USF2) is a basic helix-loop-helix leucine zipper transcription factor, which is found in most tissues. A critical role for USF2 in cellular proliferation has been proposed based on its importance in the regulation of various cyclins and P53 and its capability to antagonize c-myc. In this p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201584

    authors: Zhang ZC,Nechushtan H,Jacob-Hirsch J,Avni D,Meyuhas O,Razin E

    更新日期:1998-02-12 00:00:00

  • GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN.

    abstract::PTEN, encoding a lipid phosphatase, is a tumor suppressor gene and is mutated in various types of cancers. It is reported to regulate G1 to S phase transition of the cell cycle by influencing the expression, protein stability and subcellular location of cyclin D1. Here, we provide evidence that PTEN modulates the tran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210033

    authors: Huang W,Chang HY,Fei T,Wu H,Chen YG

    更新日期:2007-04-12 00:00:00

  • Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks.

    abstract::The diverse checkpoint responses to DNA damage may reflect differential sensitivities by molecular components of the damage-signalling network to the type and amount of lesions. Here, we determined the kinetics of activation of the checkpoint kinases ATM and Chk2 (the latter substrate of ATM) in relation to the initia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207986

    authors: Buscemi G,Perego P,Carenini N,Nakanishi M,Chessa L,Chen J,Khanna K,Delia D

    更新日期:2004-10-07 00:00:00

  • HER2/Neu: mechanisms of dimerization/oligomerization.

    abstract::DOI: 10.1038/sj/onc/1205119 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205119

    authors: Brennan PJ,Kumagai T,Berezov A,Murali R,Greene MI

    更新日期:2002-01-10 00:00:00

  • SUMOylation inhibits FOXM1 activity and delays mitotic transition.

    abstract::The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.546

    authors: Myatt SS,Kongsema M,Man CW,Kelly DJ,Gomes AR,Khongkow P,Karunarathna U,Zona S,Langer JK,Dunsby CW,Coombes RC,French PM,Brosens JJ,Lam EW

    更新日期:2014-08-21 00:00:00

  • IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.

    abstract::Recently, we identified Insulinoma-Glucagonoma clone 20 (IG20) that can render cells more susceptible to tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis. In addition, it can slow cell proliferation, and enhance drug- and radiation-induced cell death. TNF-related apoptosis-inducing ligand (TRAIL) can selectiv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207804

    authors: Ramaswamy M,Efimova EV,Martinez O,Mulherkar NU,Singh SP,Prabhakar BS

    更新日期:2004-08-12 00:00:00

  • Tyrosine kinase gene expression in the mouse small intestine.

    abstract::To identify tyrosine kinases that may regulate regeneration of the mammalian intestinal epithelium, we amplified portions of the catalytic domains of protein kinases expressed in intestinal crypt cells, using the polymerase chain reaction technique with primers directed against two invariant amino acid sequence motifs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Siyanova EY,Serfas MS,Mazo IA,Tyner AL

    更新日期:1994-07-01 00:00:00

  • Detection of PTEN nonsense mutation and psiPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay.

    abstract::We have developed a new yeast-based assay for the detection of PTEN nonsense mutation, and applied it to a total of 42 astrocytic tumors. The assay utilizes homologous recombination of PCR-amplified PTEN cDNA samples to a yeast vector which expresses an in-frame PTEN::ADE2 chimera protein. An allele of nonsense mutati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203795

    authors: Zhang CL,Tada M,Kobayashi H,Nozaki M,Moriuchi T,Abe H

    更新日期:2000-09-07 00:00:00

  • Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand-receptor 1 (TRAIL-R1) and tumor necrosis factor-related apoptosis-inducing ligand-receptor 2 (TRAIL-R2) are cell-surface receptors involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling. TRAIL-R1 and TRAIL-R2 gene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204103

    authors: Lee SH,Shin MS,Kim HS,Lee HK,Park WS,Kim SY,Lee JH,Han SY,Park JY,Oh RR,Kang CS,Kim KM,Jang JJ,Nam SW,Lee JY,Yoo NJ

    更新日期:2001-01-18 00:00:00

  • Current role of antibody therapy in patients with metastatic colorectal cancer.

    abstract::In less than 10 years, the number and importance of non-surgical treatment modalities in patients with colorectal cancer (CRC) have increased dramatically, both in the adjuvant and the advanced settings. However, despite the improvement of cytotoxic therapy in CRC, many patients still develop progressive disease and u...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210377

    authors: Pfeiffer P,Qvortrup C,Eriksen JG

    更新日期:2007-05-28 00:00:00

  • Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer.

    abstract::The precise genetic mechanism of malignant transformation in DNA mismatch repair deficient, microsatellite-unstable colorectal cancer (CRC) has yet to be elucidated. We employed cDNA microarray to identify patterns of gene expression among CRC cell lines and to compare directly lines with and without microsatellite in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206609

    authors: Yuan Z,Sotsky Kent T,Weber TK

    更新日期:2003-09-18 00:00:00

  • PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair.

    abstract::The role of poly (ADP-ribose) polymerase 1 (PARP1) in cancer has been extensively studied in the context of DNA repair, leading to clinical trials of PARP1 inhibitors in cancers defective in homologous recombination. However, the DNA repair-independent roles of PARP1 in carcinogenesis and metastasis, particularly in l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.3

    authors: Choi EB,Yang AY,Kim SC,Lee J,Choi JK,Choi C,Kim MY

    更新日期:2016-09-01 00:00:00

  • Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.

    abstract::The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matrix remodeling factors, and might be implicated in disease progression of breast cancer. In the present study, the prognostic value of Ets-1 expression was assessed by quantitative real-time fluorescence RT-PCR in 123 sp...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206040

    authors: Span PN,Manders P,Heuvel JJ,Thomas CM,Bosch RR,Beex LV,Sweep CG

    更新日期:2002-12-05 00:00:00

  • The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.

    abstract::Inter-alpha-trypsin inhibitors (ITIs) are protease inhibitors stabilizing the extracellular matrix. ITIs consist of one light (bikunin) and two heavy chains (ITIHs). We have recently characterized ITIH5, a novel member of the ITIH gene family, and showed that its messenger RNA is lost in a high proportion of breast tu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210669

    authors: Veeck J,Chorovicer M,Naami A,Breuer E,Zafrakas M,Bektas N,Dürst M,Kristiansen G,Wild PJ,Hartmann A,Knuechel R,Dahl E

    更新日期:2008-01-31 00:00:00

  • Methyltransferase inhibition induces p53-dependent apoptosis and a novel form of cell death.

    abstract::We have analysed the importance of proper substrate methylation by S-adenosylmethionine-dependent methyltransferases for cell survival and cell cycle progression. We show that treatment of cells with the methyltransferase inhibitor adenosine dialdehyde (AdOx) causes cell cycle arrest and death in different cell types....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208855

    authors: Schwerk C,Schulze-Osthoff K

    更新日期:2005-10-27 00:00:00

  • Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.

    abstract::Mouse plasmacytomas induced by pristane oil alone, or in combination with Abelson murine leukemia virus (A-MuLV), regularly carry one of three alternative chromosomal translocations that juxtapose c-myc to immunoglobulin heavy- or light-chain loci. E mu-c-myc transgenic mice develop translocation-free plasmacytomas af...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wang Y,Sugiyama H,Axelson H,Panda CK,Babonits M,Ma A,Steinberg JM,Alt FW,Klein G,Wiener F

    更新日期:1992-06-01 00:00:00

  • The human papillomavirus E6 protein and its contribution to malignant progression.

    abstract::The human papillomavirus (HPV) E6 protein is one of three oncoproteins encoded by the virus. It has long been recognized as a potent oncogene and is intimately associated with the events that result in the malignant conversion of virally infected cells. In order to understand the mechanisms by which E6 contributes to ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204869

    authors: Mantovani F,Banks L

    更新日期:2001-11-26 00:00:00